Medical Necessity: I. Autologous pancreatic islet cell transplantation: The Company considers autologous pancreatic islet cell transplantation (CPT Code 48160 and ICD-10-CM Procedure Codes 3E0. 30U0, 3E0.
ICD-10-CM Code for Pancreas transplant status Z94. 83.
ICD-10-CM Code for Stem cells transplant status Z94. 84.
Encounter for examination of potential donor of organ and tissue. Z00. 5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Islet Cell Transplantation Procedure In islet transplantation, islets are taken from the pancreas of a deceased organ donor. The islets are purified, processed, and transferred into another person. Once implanted, the beta cells in these islets begin to make and release insulin.
ICD-10 code Z94. 0 for Kidney transplant status is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Use procedure code 38241 to report the transplantation of autologous peripheral stem cells.
CPT® 38230, Under Bone Marrow or Stem Cell Services/Procedures.
Limbal stem cell transplantation is a surgical treatment to address LSCD and restore a corneal epithelial phenotype. Based on the source of cells, limbal transplant can be autologous or allogenic. Many surgical techniques are defined according to the source of the stem cells and the carrier tissues that are used.
Awaiting organ transplant statusICD-10 code Z76. 82 for Awaiting organ transplant status is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 Code for Atherosclerotic heart disease of native coronary artery without angina pectoris- I25. 10- Codify by AAPC.
ICD-10 Codes for Kidney Transplant Rejection and Failure 1 code for kidney transplant rejection or failure specified as either T86. 100 for kidney transplant rejection or as T86. 101 for kidney transplant failure.
The 2022 edition of ICD-10-CM T86.5 became effective on October 1, 2021.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
Autologous islet transplantation, performed in conjunction with pancreatectomy, is proposed to reduce thelikelihood of insulin-dependent diabetes. Moreover, allogeneic islet cell transplantation is beinginvestigated as a treatment or cure for patients with type 1 diabetes.
In autologous islet transplantation, during the pancreatectomy procedure, islet cells are isolated from theresected pancreas using enzymes, and a suspension of the cells is injected into the portal vein of thepatient’s liver. Once implanted, the beta cells in these islets begin to make and release insulin. In thecase of allogeneic islet cell transplantation, cells are harvested from the deceased donor’s pancreas,processed, and injected into the recipient’s portal vein. Up to 3 donor pancreas transplants may berequired to achieve insulin independence. Allogeneic transplantation may be performed in the radiologydepartment.
The transplant is performed on patients with Type I diabetes. A typical islet cell transplant requires over 500,000 islet cells, but varies depending on the recipient’s weight. One of the desired patient outcomes is insulin independence. Elimination of clinically significant hypoglycemia episodes and improved glucose control are other important patient outcomes.
07/2004 - Covered costs of transplantation of pancreatic islet cell, but only in context of an NIH-sponsored clinical trial. Effective date 10/01/2004 . Implementation date 10/04/2004 . ( TN 18 ) (CR 3385)
02/2017 - This change request (CR) is the 10th maintenance update of ICD-10 conversions and other coding updates specific to national coverage determinations (NCDs). These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received. Previous NCD coding changes appear in ICD-10 quarterly updates as follows: CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, CR9631, and CR9751, as well as in CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent, quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 1792 ) (CR9861)
01/2013 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy.Implementation date: 04/01/2013 Effective date: 10/1/2015. ( TN 1165 ) (CR 8109)
Medicare will pay for the routine costs, as well as transplantation and appropriate related items and services, for Medicare beneficiaries participating in a National Institutes of Health (NIH)-sponsored clinical trial (s). The term 'routine costs' means reasonable and necessary routine patient care costs, including immunosuppressive drugs and other follow-up care, as defined in section 310.1 of the NCD Manual.
Specifically, Medicare will cover transplantation of pancreatic islet cells, the insulin producing cells of the pancreas. Coverage will include the costs of acquisition and delivery of the pancreatic islet cells, as well as clinically necessary inpatient and outpatient medical care and immunosuppressants.